{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:57:06Z","timestamp":1791219426338,"version":"4.1.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-021-00250-4","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T16:04:33Z","timestamp":1631808273000},"page":"879-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Moving pan-cancer studies from basic research toward the clinic"],"prefix":"10.1038","volume":"2","author":[{"given":"Feng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Wendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-551X","authenticated-orcid":false,"given":"Matthew A.","family":"Wyczalkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-281X","authenticated-orcid":false,"given":"Yize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1517-2975","authenticated-orcid":false,"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"250_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860\u2013921 (2001).","journal-title":"Nature"},{"key":"250_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1101\/gr.157602.113","volume":"23","author":"DA Wheeler","year":"2013","unstructured":"Wheeler, D. A. & Wang, L. From human genome to cancer genome: the first decade. Genome Res. 23, 1054\u20131062 (2013).","journal-title":"Genome Res."},{"key":"250_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature08629","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184\u2013190 (2010).","journal-title":"Nature"},{"key":"250_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nature08489","volume":"461","author":"SP Shah","year":"2009","unstructured":"Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809\u2013813 (2009).","journal-title":"Nature"},{"key":"250_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature07485","volume":"456","author":"TJ Ley","year":"2008","unstructured":"Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66\u201372 (2008).","journal-title":"Nature"},{"key":"250_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685\u2013689 (2012).","journal-title":"Nat. Genet."},{"key":"250_CR7","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","volume":"19","author":"JF Gainor","year":"2013","unstructured":"Gainor, J. F. et al. ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin. Cancer Res. 19, 4273\u20134281 (2013).","journal-title":"Clin. Cancer Res."},{"key":"250_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"250_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765\u2013773 (2009).","journal-title":"N. Engl. J. Med."},{"key":"250_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"250_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506\u2013510 (2012).","journal-title":"Nature"},{"key":"250_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"The Cancer Genome Atlas Research Ne","year":"2013","unstructured":"The Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"250_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cell.2018.03.033","volume":"173","author":"L Ding","year":"2018","unstructured":"Ding, L. et al. Perspective on oncogenic processes at the end of the beginning of cancer genomics. Cell 173, 305\u2013320 (2018).","journal-title":"Cell"},{"key":"250_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","volume":"173","author":"C Hutter","year":"2018","unstructured":"Hutter, C. & Zenklusen, J. C. The Cancer Genome Atlas: creating lasting value beyond its data. Cell 173, 283\u2013285 (2018).","journal-title":"Cell"},{"key":"250_CR15","unstructured":"ICGC\/TCGA Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020)."},{"key":"250_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1126\/science.aai7862","volume":"353","author":"DS Singer","year":"2016","unstructured":"Singer, D. S., Jacks, T. & Jaffee, E. A US \u201cCancer Moonshot\u201d to accelerate cancer research. Science 353, 1105\u20131106 (2016).","journal-title":"Science"},{"key":"250_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA Pan-Cancer Clinical Data Resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 (2018).","journal-title":"Cell"},{"key":"250_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45165-4","volume":"9","author":"DMA Gendoo","year":"2019","unstructured":"Gendoo, D. M. A. et al. MetaGxData: clinically annotated breast, ovarian and pancreatic cancer datasets and their use in generating a multi-cancer gene signature. Sci. Rep. 9, 8770 (2019).","journal-title":"Sci. Rep."},{"key":"250_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2020.03.053","volume":"181","author":"O Rozenblatt-Rosen","year":"2020","unstructured":"Rozenblatt-Rosen, O. et al. The Human Tumor Atlas Network: charting tumor transitions across space and time at single-cell resolution. Cell 181, 236\u2013249 (2020).","journal-title":"Cell"},{"key":"250_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark, D. J. et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983 (2019).","journal-title":"Cell"},{"key":"250_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","volume":"180","author":"Y Dou","year":"2020","unstructured":"Dou, Y. et al. Proteogenomic characterization of endometrial carcinoma. Cell 180, 729\u2013748 (2020).","journal-title":"Cell"},{"key":"250_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225 (2020).","journal-title":"Cell"},{"key":"250_CR23","doi-asserted-by":"crossref","unstructured":"AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov. 7, 818\u2013831 (2017).","DOI":"10.1158\/2159-8290.CD-17-0151"},{"key":"250_CR24","unstructured":"McLeod, C. et al. St. Jude Cloud: a pediatric cancer genomic data sharing ecosystem. Cancer Discov. 11, 1082\u20131099 (2021)."},{"key":"250_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Grobner","year":"2018","unstructured":"Grobner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321\u2013327 (2018).","journal-title":"Nature"},{"key":"250_CR26","doi-asserted-by":"crossref","unstructured":"The International Cancer Genome Consortium. International network of cancer genome projects. Nature 464, 993\u2013998 (2010).","DOI":"10.1038\/nature08987"},{"key":"250_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep02650","volume":"3","author":"D Tamborero","year":"2013","unstructured":"Tamborero, D. et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3, 2650 (2013).","journal-title":"Sci. Rep."},{"key":"250_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333\u2013339 (2013).","journal-title":"Nature"},{"key":"250_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495\u2013501 (2014).","journal-title":"Nature"},{"key":"250_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385 (2018).","journal-title":"Cell"},{"key":"250_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane, D. P. Cancer. p53, guardian of the genome. Nature 358, 15\u201316 (1992).","journal-title":"Nature"},{"key":"250_CR32","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"250_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"KL Huang","year":"2018","unstructured":"Huang, K. L. et al. Pathogenic germline variants in 10,389 adult cancers. Cell 173, 355\u2013370 (2018).","journal-title":"Cell"},{"key":"250_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","journal-title":"Nat. Genet."},{"key":"250_CR35","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929\u2013944 (2014).","journal-title":"Cell"},{"key":"250_CR36","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"250_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304 (2018).","journal-title":"Cell"},{"key":"250_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"250_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2019.06.005","volume":"36","author":"NG Balanis","year":"2019","unstructured":"Balanis, N. G. et al. Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies. Cancer Cell 36, 17\u201334 (2019).","journal-title":"Cancer Cell"},{"key":"250_CR40","first-page":"101","volume":"2","author":"P Mendez","year":"2013","unstructured":"Mendez, P. & Ramirez, J. L. Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung. Transl. Lung Cancer Res. 2, 101\u2013111 (2013).","journal-title":"Transl. Lung Cancer Res."},{"key":"250_CR41","doi-asserted-by":"publisher","first-page":"51.e51","DOI":"10.1016\/j.ajog.2015.02.001","volume":"213","author":"TC Wright","year":"2015","unstructured":"Wright, T. C. et al. Amplification of the 3q chromosomal region as a specific marker in cervical cancer. Am. J. Obstet. Gynecol. 213, 51.e51\u201351.e58 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"250_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"The Cancer Genome Atlas Network","year":"2015","unstructured":"The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015).","journal-title":"Nature"},{"key":"250_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","volume":"48","author":"VF Muglia","year":"2015","unstructured":"Muglia, V. F. & Prando, A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol. Bras. 48, 166\u2013174 (2015).","journal-title":"Radiol. Bras."},{"key":"250_CR44","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","volume":"14","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Multilevel genomics-based taxonomy of renal cell carcinoma. Cell Rep. 14, 2476\u20132489 (2016).","journal-title":"Cell Rep."},{"key":"250_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts, C. J. et al. The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 23, 313\u2013326 (2018).","journal-title":"Cell Rep."},{"key":"250_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/path.5022","volume":"244","author":"JJ Hsieh","year":"2018","unstructured":"Hsieh, J. J., Le, V., Cao, D., Cheng, E. H. & Creighton, C. J. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision. J. Pathol. 244, 525\u2013537 (2018).","journal-title":"J. Pathol."},{"key":"250_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18632\/oncotarget.13346","volume":"8","author":"M Chen","year":"2017","unstructured":"Chen, M., Liu, X., Du, J., Wang, X. J. & Xia, L. Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers. Oncotarget 8, 133\u2013144 (2017).","journal-title":"Oncotarget"},{"key":"250_CR48","doi-asserted-by":"crossref","unstructured":"Wen, P. et al. Pan-cancer analysis of radiotherapy benefits and immune infiltration in multiple human cancers. Cancers 12, 957 (2020).","DOI":"10.3390\/cancers12040957"},{"key":"250_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"250_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/php.12377","volume":"91","author":"DE Brash","year":"2015","unstructured":"Brash, D. E. UV signature mutations. Photochem. Photobiol. 91, 15\u201326 (2015).","journal-title":"Photochem. Photobiol."},{"key":"250_CR51","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1126\/science.aag0299","volume":"354","author":"LB Alexandrov","year":"2016","unstructured":"Alexandrov, L. B. et al. Mutational signatures associated with tobacco smoking in human cancer. Science 354, 618\u2013622 (2016).","journal-title":"Science"},{"key":"250_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep28294","volume":"6","author":"S Cao","year":"2016","unstructured":"Cao, S. et al. Divergent viral presentation among human tumors and adjacent normal tissues. Sci. Rep. 6, 28294 (2016).","journal-title":"Sci. Rep."},{"key":"250_CR53","doi-asserted-by":"publisher","first-page":"a016600","DOI":"10.1101\/cshperspect.a016600","volume":"7","author":"R Prakash","year":"2015","unstructured":"Prakash, R., Zhang, Y., Feng, W. & Jasin, M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb. Perspect. Biol. 7, a016600 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"250_CR54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies, H. et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat. Med. 23, 517\u2013525 (2017).","journal-title":"Nat. Med."},{"key":"250_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19406-4","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen, L., John, W. M. M., Van Hoeck, A. & Cuppen, E. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).","journal-title":"Nat. Commun."},{"key":"250_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","volume":"571","author":"P Jonsson","year":"2019","unstructured":"Jonsson, P. et al. Tumour lineage shapes BRCA-mediated phenotypes. Nature 571, 576\u2013579 (2019).","journal-title":"Nature"},{"key":"250_CR57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.aau0447","volume":"364","author":"R Mandal","year":"2019","unstructured":"Mandal, R. et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science 364, 485\u2013491 (2019).","journal-title":"Science"},{"key":"250_CR58","doi-asserted-by":"publisher","first-page":"106088","DOI":"10.1016\/j.intimp.2019.106088","volume":"79","author":"L Wang","year":"2020","unstructured":"Wang, L., Ma, Q., Yao, R. & Liu, J. Current status and development of anti-PD-1\/PD-L1 immunotherapy for lung cancer. Int. Immunopharmacol. 79, 106088 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"250_CR59","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause, R. J., Pritchard, C. C., Shendure, J. & Salipante, S. J. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342\u20131350 (2016).","journal-title":"Nat. Med."},{"key":"250_CR60","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu, B. et al. MSIsensor: microsatellite instability detection using paired tumor\u2013normal sequence data. Bioinformatics 30, 1015\u20131016 (2014).","journal-title":"Bioinformatics"},{"key":"250_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68394-4","volume":"10","author":"C Heydt","year":"2020","unstructured":"Heydt, C. et al. Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing. Sci. Rep. 10, 11387 (2020).","journal-title":"Sci. Rep."},{"key":"250_CR62","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1007\/s00018-018-2906-9","volume":"75","author":"M Ratti","year":"2018","unstructured":"Ratti, M., Lampis, A., Hahne, J. C., Passalacqua, R. & Valeri, N. Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell. Mol. Life Sci. 75, 4151\u20134162 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"250_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00428-015-1892-7","volume":"468","author":"A Warth","year":"2016","unstructured":"Warth, A. et al. Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases. Virchows Arch. 468, 313\u2013319 (2016).","journal-title":"Virchows Arch."},{"key":"250_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF03256208","volume":"10","author":"SE Gray","year":"2006","unstructured":"Gray, S. E., Kay, E. W., Leader, M. & Mabruk, M. J. Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Mol. Diagn. Ther. 10, 327\u2013334 (2006).","journal-title":"Mol. Diagn. Ther."},{"key":"250_CR65","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig, C. et al. The pancreas cancer microenvironment. Clin. Cancer Res. 18, 4266\u20134276 (2012).","journal-title":"Clin. Cancer Res."},{"key":"250_CR66","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"250_CR67","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker, G. S. et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat. Genet. 52, 1208\u20131218 (2020).","journal-title":"Nat. Genet."},{"key":"250_CR68","doi-asserted-by":"crossref","unstructured":"Bhandari, V., Li, C. H., Bristow, R. G., Boutros, P. C. & PCAWG Consortium. Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat. Commun. 11, 737 (2020).","DOI":"10.1101\/531996"},{"key":"250_CR69","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830 (2018).","journal-title":"Immunity"},{"key":"250_CR70","doi-asserted-by":"publisher","first-page":"15713","DOI":"10.1038\/s41598-021-95287-x","volume":"11","author":"S Mizuno","year":"2021","unstructured":"Mizuno, S. et al. Immuno-genomic pan-cancer landscape reveals diverse immune escape mechanisms and immuno-editing histories. Sci. Rep. 11, 15713 (2021).","journal-title":"Sci. Rep."},{"key":"250_CR71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0300-2896(15)30428-2","volume":"34","author":"P Navio","year":"1998","unstructured":"Navio, P., Hernandez Madrid, A. & de Farges, V. [Iatrogenic massive pleural effusion and cardiac tamponade]. Arch. Bronconeumol. 34, 318 (1998).","journal-title":"Arch. Bronconeumol."},{"key":"250_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","volume":"6","author":"P Danaher","year":"2018","unstructured":"Danaher, P. et al. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from the Cancer Genome Atlas (TCGA). J. Immunother. Cancer 6, 63 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"250_CR73","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","volume":"33","author":"AC Berger","year":"2018","unstructured":"Berger, A. C. et al. A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell 33, 690\u2013705 (2018).","journal-title":"Cancer Cell"},{"key":"250_CR74","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cell.2018.03.027","volume":"173","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. A pan-cancer analysis of enhancer expression in nearly 9000 patient samples. Cell 173, 386\u2013399 (2018).","journal-title":"Cell"},{"key":"250_CR75","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep. 25, 1304\u20131317 (2018).","journal-title":"Cell Rep."},{"key":"250_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14367-0","volume":"11","author":"MA Reyna","year":"2020","unstructured":"Reyna, M. A. et al. Pathway and network analysis of more than 2500 whole cancer genomes. Nat. Commun. 11, 729 (2020).","journal-title":"Nat. Commun."},{"key":"250_CR77","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.3774","volume":"49","author":"M Griffith","year":"2017","unstructured":"Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat. Genet. 49, 170\u2013174 (2017).","journal-title":"Nat. Genet."},{"key":"250_CR78","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 2017, PO.17.00011 (2017)."},{"key":"250_CR79","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-med-062016-050343","volume":"69","author":"JJ Tao","year":"2018","unstructured":"Tao, J. J., Schram, A. M. & Hyman, D. M. Basket studies: redefining clinical trials in the era of genome-driven oncology. Annu. Rev. Med. 69, 319\u2013331 (2018).","journal-title":"Annu. Rev. Med."},{"key":"250_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ctrv.2018.04.006","volume":"66","author":"A Leonetti","year":"2018","unstructured":"Leonetti, A. et al. BRAF in non-small cell lung cancer (NSCLC): pickaxing another brick in the wall. Cancer Treat. Rev. 66, 82\u201394 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"250_CR81","doi-asserted-by":"crossref","unstructured":"Raje, N. et al. Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAFV600 mutations: a cohort of the histology-independent VE-BASKET study. JCO Precis. Oncol. 2, PO.18.00070 (2018).","DOI":"10.1200\/PO.18.00070"},{"key":"250_CR82","doi-asserted-by":"crossref","unstructured":"Kopetz, S. et al. Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406). J. Clin. Oncol. 39, 285\u2013294 (2020).","DOI":"10.1200\/JCO.20.01994"},{"key":"250_CR83","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","volume":"373","author":"DM Hyman","year":"2015","unstructured":"Hyman, D. M. et al. Vemurafenib in multiple nonmelanoma cancers with BRAFV600 mutations. N. Engl. J. Med. 373, 726\u2013736 (2015).","journal-title":"N. Engl. J. Med."},{"key":"250_CR84","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1200\/JCO.2015.63.2471","volume":"33","author":"RB Corcoran","year":"2015","unstructured":"Corcoran, R. B. et al. Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAFV600-mutant colorectal cancer. J. Clin. Oncol. 33, 4023\u20134031 (2015).","journal-title":"J. Clin. Oncol."},{"key":"250_CR85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fonc.2019.00229","volume":"9","author":"BD Qin","year":"2019","unstructured":"Qin, B. D. et al. Basket trials for intractable cancer. Front. Oncol. 9, 229 (2019).","journal-title":"Front. Oncol."},{"key":"250_CR86","doi-asserted-by":"crossref","unstructured":"McNeil, C. NCI-MATCH launch highlights new trial design in precision-medicine era. J. Natl Cancer Inst. 107, djv193 (2015).","DOI":"10.1093\/jnci\/djv193"},{"key":"250_CR87","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4694","volume":"14","author":"A Mullard","year":"2015","unstructured":"Mullard, A. NCI-MATCH trial pushes cancer umbrella trial paradigm. Nat. Rev. Drug Discov. 14, 513\u2013515 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"250_CR88","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ygyno.2018.01.008","volume":"148","author":"L Barroilhet","year":"2018","unstructured":"Barroilhet, L. & Matulonis, U. The NCI-MATCH trial and precision medicine in gynecologic cancers. Gynecol. Oncol. 148, 585\u2013590 (2018).","journal-title":"Gynecol. Oncol."},{"key":"250_CR89","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-19-3356","volume":"26","author":"SP Patel","year":"2020","unstructured":"Patel, S. P. et al. A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART SWOG 1609) in patients with nonpancreatic neuroendocrine tumors. Clin. Cancer Res. 26, 2290\u20132296 (2020).","journal-title":"Clin. Cancer Res."},{"key":"250_CR90","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1200\/JCO.2018.77.9777","volume":"36","author":"BT Li","year":"2018","unstructured":"Li, B. T. et al. Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: results from a phase II basket trial. J. Clin. Oncol. 36, 2532\u20132537 (2018).","journal-title":"J. Clin. Oncol."},{"key":"250_CR91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/d41573-020-00015-1","volume":"19","author":"AM Looney","year":"2020","unstructured":"Looney, A. M., Nawaz, K. & Webster, R. M. Tumour-agnostic therapies. Nat. Rev. Drug Discov. 19, 383\u2013384 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"250_CR92","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"The Cancer Genome Atlas Research Ne","year":"2008","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"250_CR93","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"The Cancer Genome Atlas Research Ne","year":"2011","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"250_CR94","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"250_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"250_CR96","doi-asserted-by":"crossref","unstructured":"Levine, D. A. & the Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","DOI":"10.1038\/nature12113"},{"key":"250_CR97","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"The Cancer Genome Atlas Research Ne","year":"2013","unstructured":"The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"250_CR98","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"The Cancer Genome Atlas Research Ne","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550 (2014).","journal-title":"Nature"},{"key":"250_CR99","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"250_CR100","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan, X., Larsson, C. & Xu, D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players. Oncogene 38, 6172\u20136183 (2019).","journal-title":"Oncogene"},{"key":"250_CR101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nmeth.2769","volume":"11","author":"J Eberwine","year":"2014","unstructured":"Eberwine, J., Sul, J. Y., Bartfai, T. & Kim, J. The promise of single-cell sequencing. Nat. Methods 11, 25\u201327 (2014).","journal-title":"Nat. Methods"},{"key":"250_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.2018090912","volume":"30","author":"H Wu","year":"2019","unstructured":"Wu, H., Kirita, Y., Donnelly, E. L. & Humphreys, B. D. Advantages of single-nucleus over single-cell RNA sequencing of adult kidney: rare cell types and novel cell states revealed in fibrosis. J. Am. Soc. Nephrol. 30, 23\u201332 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"250_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11591-1","volume":"10","author":"AA Petti","year":"2019","unstructured":"Petti, A. A. et al. A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat. Commun. 10, 3660 (2019).","journal-title":"Nat. Commun."},{"key":"250_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07261-3","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma, A. et al. Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy. Nat. Commun. 9, 4931 (2018).","journal-title":"Nat. Commun."},{"key":"250_CR105","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","volume":"20","author":"DA Lawson","year":"2018","unstructured":"Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N. & Werb, Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat. Cell Biol. 20, 1349\u20131360 (2018).","journal-title":"Nat. Cell Biol."},{"key":"250_CR106","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1158\/2326-6066.CIR-18-0658","volume":"7","author":"L Zhang","year":"2019","unstructured":"Zhang, L. & Zhang, Z. Recharacterizing tumor-infiltrating lymphocytes by single-cell RNA sequencing. Cancer Immunol. Res. 7, 1040\u20131046 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"250_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0433-z","volume":"11","author":"Y Gan","year":"2018","unstructured":"Gan, Y., Li, N., Zou, G., Xin, Y. & Guan, J. Identification of cancer subtypes from single-cell RNA-seq data using a consensus clustering method. BMC Med. Genomics 11, 117 (2018).","journal-title":"BMC Med. Genomics"},{"key":"250_CR108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell 166, 755\u2013765 (2016).","journal-title":"Cell"},{"key":"250_CR109","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2014).","journal-title":"Nature"},{"key":"250_CR110","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049 (2019).","journal-title":"Cell"},{"key":"250_CR111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"250_CR112","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"250_CR113","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"250_CR114","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"250_CR115","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"250_CR116","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1093\/nar\/gkr344","volume":"39","author":"K Nakamura","year":"2011","unstructured":"Nakamura, K. et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res. 39, e90 (2011).","journal-title":"Nucleic Acids Res."},{"key":"250_CR117","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"250_CR118","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/bioinformatics\/btr193","volume":"27","author":"MC Wendl","year":"2011","unstructured":"Wendl, M. C. et al. PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics 27, 1595\u20131602 (2011).","journal-title":"Bioinformatics"},{"key":"250_CR119","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gr.134635.111","volume":"22","author":"ND Dees","year":"2012","unstructured":"Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589\u20131598 (2012).","journal-title":"Genome Res."},{"key":"250_CR120","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/bioinformatics\/btt395","volume":"29","author":"D Tamborero","year":"2013","unstructured":"Tamborero, D., Gonzalez-Perez, A. & Lopez-Bigas, N. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29, 2238\u20132244 (2013).","journal-title":"Bioinformatics"},{"key":"250_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/srep02651","volume":"3","author":"J Reimand","year":"2013","unstructured":"Reimand, J., Wagih, O. & Bader, G. D. The mutational landscape of phosphorylation signaling in cancer. Sci. Rep. 3, 2651 (2013).","journal-title":"Sci. Rep."},{"key":"250_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0994-0","volume":"17","author":"L Mularoni","year":"2016","unstructured":"Mularoni, L., Sabarinathan, R., Deu-Pons, J., Gonzalez-Perez, A. & Lopez-Bigas, N. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol. 17, 128 (2016).","journal-title":"Genome Biol."},{"key":"250_CR123","doi-asserted-by":"publisher","first-page":"14330","DOI":"10.1073\/pnas.1616440113","volume":"113","author":"CJ Tokheim","year":"2016","unstructured":"Tokheim, C. J., Papadopoulos, N., Kinzler, K. W., Vogelstein, B. & Karchin, R. Evaluating the evaluation of cancer driver genes. Proc. Natl Acad. Sci. USA 113, 14330\u201314335 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"250_CR124","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P. C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003).","journal-title":"Nucleic Acids Res."},{"key":"250_CR125","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-09-1133","volume":"69","author":"H Carter","year":"2009","unstructured":"Carter, H. et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 69, 6660\u20136667 (2009).","journal-title":"Cancer Res."},{"key":"250_CR126","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).","journal-title":"Nucleic Acids Res."},{"key":"250_CR127","doi-asserted-by":"crossref","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 76, 7.20.1\u20137.20.41 (2013).","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"250_CR128","doi-asserted-by":"publisher","first-page":"e77945","DOI":"10.1371\/journal.pone.0077945","volume":"8","author":"Y Mao","year":"2013","unstructured":"Mao, Y. et al. CanDrA: cancer-specific driver missense mutation annotation with optimized features. PLoS ONE 8, e77945 (2013).","journal-title":"PLoS ONE"},{"key":"250_CR129","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1093\/bioinformatics\/btu499","volume":"30","author":"E Porta-Pardo","year":"2014","unstructured":"Porta-Pardo, E. & Godzik, A. e-Driver: a novel method to identify protein regions driving cancer. Bioinformatics 30, 3109\u20133114 (2014).","journal-title":"Bioinformatics"},{"key":"250_CR130","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1158\/0008-5472.CAN-15-3190","volume":"76","author":"C Tokheim","year":"2016","unstructured":"Tokheim, C. et al. Exome-scale discovery of hotspot mutation regions in human cancer using 3D protein structure. Cancer Res. 76, 3719\u20133731 (2016).","journal-title":"Cancer Res."},{"key":"250_CR131","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ng.3586","volume":"48","author":"B Niu","year":"2016","unstructured":"Niu, B. et al. Protein-structure-guided discovery of functional mutations across 19 cancer types. Nat. Genet. 48, 827\u2013837 (2016).","journal-title":"Nat. Genet."},{"key":"250_CR132","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.3559","volume":"20","author":"EM Van Allen","year":"2014","unstructured":"Van Allen, E. M. et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat. Med. 20, 682\u2013688 (2014).","journal-title":"Nat. Med."},{"key":"250_CR133","doi-asserted-by":"publisher","first-page":"D1073","DOI":"10.1093\/nar\/gky984","volume":"47","author":"N Conte","year":"2019","unstructured":"Conte, N. et al. PDX Finder: a portal for patient-derived tumor xenograft model discovery. Nucleic Acids Res. 47, D1073\u2013D1079 (2019).","journal-title":"Nucleic Acids Res."},{"key":"250_CR134","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4939-9145-7_15","volume":"1953","author":"LC Yao","year":"2019","unstructured":"Yao, L. C. et al. Creation of PDX-bearing humanized mice to study immuno-oncology. Methods Mol. Biol. 1953, 241\u2013252 (2019).","journal-title":"Methods Mol. Biol."},{"key":"250_CR135","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"250_CR136","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 (2017).","journal-title":"Cell"},{"key":"250_CR137","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","volume":"25","author":"H Li","year":"2019","unstructured":"Li, H. et al. The landscape of cancer cell line metabolism. Nat. Med. 25, 850\u2013860 (2019).","journal-title":"Nat. Med."},{"key":"250_CR138","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fgene.2020.00446","volume":"11","author":"SE Wallace","year":"2020","unstructured":"Wallace, S. E., Kirby, E. & Knoppers, B. M. How can we not waste legacy genomic research data? Front. Genet. 11, 446 (2020).","journal-title":"Front. Genet."},{"key":"250_CR139","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom, Q. T. et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 21, v1\u2013v100 (2019).","journal-title":"Neuro Oncol."},{"key":"250_CR140","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2214\/AJR.07.3568","volume":"191","author":"CS Ng","year":"2008","unstructured":"Ng, C. S. et al. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am. J. Roentgenol. 191, 1220\u20131232 (2008).","journal-title":"AJR Am. J. Roentgenol."},{"key":"250_CR141","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","volume":"23","author":"JJ Patard","year":"2005","unstructured":"Patard, J. J. et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J. Clin. Oncol. 23, 2763\u20132771 (2005).","journal-title":"J. Clin. Oncol."},{"key":"250_CR142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"250_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0063-y","volume":"9","author":"TV Denisenko","year":"2018","unstructured":"Denisenko, T. V., Budkevich, I. N. & Zhivotovsky, B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 9, 117 (2018).","journal-title":"Cell Death Dis."},{"key":"250_CR144","doi-asserted-by":"publisher","first-page":"e1002162","DOI":"10.1371\/journal.pmed.1002162","volume":"13","author":"J Shi","year":"2016","unstructured":"Shi, J. et al. Somatic genomics and clinical features of lung adenocarcinoma: a retrospective study. PLoS Med. 13, e1002162 (2016).","journal-title":"PLoS Med."},{"key":"250_CR145","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#","volume":"75","author":"M Noguchi","year":"1995","unstructured":"Noguchi, M. et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75, 2844\u20132852 (1995).","journal-title":"Cancer"},{"key":"250_CR146","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.eururo.2013.11.004","volume":"65","author":"A Znaor","year":"2014","unstructured":"Znaor, A., Lortet-Tieulent, J., Jemal, A. & Bray, F. International variations and trends in testicular cancer incidence and mortality. Eur. Urol. 65, 1095\u20131106 (2014).","journal-title":"Eur. Urol."},{"key":"250_CR147","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels, E. A. Epidemiology of thymoma and associated malignancies. J. Thorac. Oncol. 5, S260\u2013S265 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"250_CR148","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00000658-199910000-00012","volume":"230","author":"KB Wilkins","year":"1999","unstructured":"Wilkins, K. B. et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann. Surg. 230, 562\u2013572 (1999).","journal-title":"Ann. Surg."},{"key":"250_CR149","first-page":"e10283","volume":"12","author":"N Nama","year":"2020","unstructured":"Nama, N. et al. Carcinosarcoma of the uterus: a study from the Surveillance Epidemiology and End Result (SEER) database. Cureus 12, e10283 (2020).","journal-title":"Cureus"},{"key":"250_CR150","unstructured":"Steinweber, P. & Koller A., Similar Diversity (Photograph). Hanger-7, Salzburg, Austria. In Visual Complexity Mapping Patterns of Information (ed., Lima, M.) 124\u2013125 (Princeton Architectural Press, 2013)."},{"key":"250_CR151","unstructured":"Sanchez, G. Arcdiagram: plot pretty arc diagrams. R package version 0.1.11 (2014)."},{"key":"250_CR152","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00250-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T06:02:59Z","timestamp":1675663379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00250-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":152,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1038\/s43018-021-00250-4","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}